Scor­pi­on scores $65M as it lines up a part­ner to take EGFR pro­grams glob­al

Ax­el Hoos is fir­ing up an­oth­er cylin­der in pur­suit of Scor­pi­on Ther­a­peu­tics’ vi­sion for pre­ci­sion on­col­o­gy 2.0, and it in­volves bring­ing a Eu­ro­pean play­er to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER